Targeting the latest hallmark of cancer : another attempt at 'magic bullet' drugs targeting cancers' metabolic phenotype

Download
  1. Get@NRC: Targeting the latest hallmark of cancer : another attempt at 'magic bullet' drugs targeting cancers' metabolic phenotype (Opens in a new window)
DOIResolve DOI: http://doi.org/10.2217/fon.12.121
AuthorSearch for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleFuture Oncology
Volume8
Issue10
Pages13151330; # of pages: 15
AbstractThe metabolism of tumors is remarkably different from the metabolism of corresponding normal cells and tissues. Metabolic alterations are initiated by oncogenes and are required for malignant transformation, allowing cancer cells to resist some cell death signals while producing energy and fulfilling their biosynthetic needs with limiting resources. The distinct metabolic phenotype of cancers provides an interesting avenue for treatment, potentially with minimal side effects. As many cancers show similar metabolic characteristics, drugs targeting the cancer metabolic phenotype are, perhaps optimistically, expected to be 'magic bullet' treatments. Over the last few years there have been a number of potential drugs developed to specifically target cancer metabolism. Several of these drugs are currently in clinical and preclinical trials. This review outlines examples of drugs developed for different targets of significance to cancer metabolism, with a focus on small molecule leads, chemical biology and clinical results for these drugs.
Publication date
PublisherFuture Medicine
LanguageEnglish
AffiliationNational Research Council Canada; Information and Communication Technologies
Peer reviewedYes
NPARC number21263934
Export citationExport as RIS
Report a correctionReport a correction
Record identifierc637aaf5-b210-4043-b1ab-ddeef7ed8212
Record created2013-03-18
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)